Accueil/Actions/NRSN

NRSN

USD

NeuroSense Therapeutics Ltd. Ordinary Shares

$1.040-0.010 (-0.952%)

Prix en Temps Réel

Healthcare

Biotechnologie

Israël

Graphique des Prix

Loading Chart...

Métriques Clés

Métriques de Marché

Fondamentaux de l'Entreprise

Statistiques de Trading

Métriques de Marché

Ouverture

$1.050

Haut

$1.100

Bas

$1.020

Volume

0.03M

Fondamentaux de l'Entreprise

Capitalisation Boursière

30.7M

Industrie

Biotechnologie

Pays

Israel

Statistiques de Trading

Volume Moyen

0.60M

Bourse

NCM

Devise

USD

Intervalle sur 52 Semaines

Bas $0.8Actuel $1.040Haut $2.6

Rapport d'Analyse IA

Dernière mise à jour: 31 oct. 2025

Généré par l'IASource des Données: Yahoo Finance, Bloomberg, SEC

NRSN: A Biotech Bargain With Technical Headwinds

Overview

NeuroSense Therapeutics Ltd (NRSN) trades at $1.03 as of October 30, 2025, nearing its 52-week low of $0.80. The clinical-stage biotech focuses on ALS, Alzheimer's, and Parkinson's treatments, with PrimeC in late-stage trials. Despite a bearish technical setup, its P/E ratio (-1.88x) undercuts the industry average (-2.8x), suggesting potential undervaluation.

Key Technical Signals

Weak Bearish Momentum

DMI Indicator: A bearish trend is detected (ADX:13.2, +DI:8.8, -DI:16.7), though weak trend strength reduces reliability.
MACD Death Cross: Bearish momentum with MACD (-0.0026) below signal line (-0.0022), but the narrow gap implies limited urgency.